Nomifensine: A potent dopaminergic agonist of antiparkinson potential
- 1 January 1975
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 41 (2), 153-164
- https://doi.org/10.1007/bf00421073
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nucleiEuropean Journal of Pharmacology, 1974
- Design of agents for stimulation of neostriatal dopaminergic mechanismsJournal of Pharmacy and Pharmacology, 1974
- Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topographyNature, 1974
- Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatumJournal of Pharmacy and Pharmacology, 1974
- Extrapyramidal and mesolimbic involvement with the stereotypic activity of D- and L-amphetamineEuropean Journal of Pharmacology, 1974
- DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITYJournal of Neurochemistry, 1974
- The role of telencephalic dopaminergic systems in the mediation of apomorphine-sterrotyped behaviourEuropean Journal of Pharmacology, 1973
- Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugsJournal of Pharmacy and Pharmacology, 1972
- Tremor Inhibition in Parkinson Syndrome After Apomorphine Administration Under L-Dopa and Decarboxylase-Inhibitor Basic TherapyPharmacopsychiatry, 1972
- Evidence for dopamine receptor stimulation by apomorphineJournal of Pharmacy and Pharmacology, 1967